JOINT FILING AGREEMENTJoint Filing Agreement • August 1st, 2022 • Camac Fund, LP • Pharmaceutical preparations
This JOINT FILING AGREEMENT is entered into as of December 30, 2019, by and among the signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of Common Stock of Forte Biosciences, Inc., and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
